Retraction Note to: Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells.

Panka, David J; Liu, Qingjun; Geissler, Andrew K; Mier, James W

Panka, David J; Liu, Qingjun; Geissler, Andrew K; Mier, James W.

Afiliação

Panka DJ; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA. dpanka@bidmc.harvard.edu.
Liu Q; , 330 Brookline Avenue, RW-571, Boston, MA, 02215, USA. dpanka@bidmc.harvard.edu.
Geissler AK; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Mier JW; Division of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Mol Cancer ; 20(1): 89, 2021 Jun 11.

Article em En | MEDLINE | ID: mdl-34116693

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google